Cascade Textures and SUSY SO(10) GUT

We give texture analyses of cascade hierarchical mass matrices in supersymmetric SO(10) grand unified theory. We embed cascade mass textures of the standard model fermion with right-handed neutrinos into the theory, which gives relations among the mass matrices of the fermions. The related phenomenologies, such as the lepton flavor violating processes and leptogenesis, are also investigated in addition to the PMNS mixing angles.Comment: 27 pages, 4 figures, comments and references added, final versio

Charged Lepton Flavour Violating Radiative Decays ℓi→ℓj+γ\ell_i \to \ell_j + \gamma in See-Saw Models with A4A_4 Symmetry

The charged lepton flavour violating (LFV) radiative decays, $\mu\to e+\gamma$, $\tau\to \mu+\gamma$ and $\tau\to e +\gamma$ are investigated in a class of supersymmetric $A_4$ models with three heavy right-handed (RH) Majorana neutrinos, in which the lepton (neutrino) mixing is predicted to leading order (LO) to be tri-bimaximal. The light neutrino masses are generated via the type I see-saw mechanism. The analysis is done within the framework of the minimal supergravity (mSUGRA) scenario, which provides flavour universal boundary conditions at the scale of grand unification $M_X \approx 2 \times 10^{16}$ GeV. Detailed predictions for the rates of the three LFV decays are obtained in two explicit realisations of the $A_4$ models due to Altarelli and Feruglio and Altarelli and Meloni, respectively.Comment: Results unchanged, minor improvements made; version accepted for publication in JHE

Search for lepton-flavour-violating decays of the Higgs and Z bosons with the ATLAS detector

Direct searches for lepton flavour violation in decays of the Higgs and Z bosons with the ATLAS detector at the LHC are presented. The following three decays are considered: H→eτ, H→μτ, and Z→μτ. The searches are based on the data sample of proton–proton collisions collected by the ATLAS detector corresponding to an integrated luminosity of 20.3 fb−1 at a centre-of-mass energy of s√=8 TeV. No significant excess is observed, and upper limits on the lepton-flavour-violating branching ratios are set at the 95 % confidence level: Br (H→eτ)<1.04%, Br (H→μτ)<1.43%, and Br (Z→μτ)<1.69×10−5

Search for lepton-flavour-violating H → μτ decays of the Higgs boson with the ATLAS detector

A direct search for lepton-flavour-violating H → μτ decays of the recently discovered Higgs boson with the ATLAS detector at the LHC is presented. The analysis is performed in the H → μτ had channel, where τ had is a hadronically decaying τ -lepton. The search is based on the data sample of proton-proton collisions collected by the ATLAS experiment corresponding to an integrated luminosity of 20.3 fb−1 at a centre-of-mass energy of s √ =8 s=8 TeV. No statistically significant excess of data over the predicted background is observed. The observed (expected) 95% confidence-level upper limit on the branching fraction, Br(H → μτ ), is 1.85% (1.24%)

Hand osteoarthritis: clinical phenotypes, molecular mechanisms and disease management

Osteoarthritis (OA) is a highly prevalent condition and the hand is the most commonly affected site. Patients with hand OA frequently report symptoms of pain, functional limitations, and frustration in undertaking everyday activities. The condition presents clinically with changes to the bone, ligaments, cartilage and synovial tissue, which can be observed using radiography, ultrasonography or MRI. Hand OA is a heterogeneous disorder and is considered to be multifactorial in aetiology. This review provides an overview of the epidemiology, presentation and burden of hand OA, including an update on hand OA imaging (including the development of novel techniques), disease mechanisms and management. In particular, areas for which new evidence has substantially changed the way we understand, consider and treat hand OA are highlighted. For example, genetic studies, clinical trials and careful prospective imaging studies from the past 5 years are beginning to provide insights into the pathogenesis of hand OA that might uncover new therapeutic targets in disease